Omentin: A Key Player in Glucose Homeostasis, Atheroprotection, and Anti-Inflammatory Potential for Cardiovascular Health in Obesity and Diabetes
CM Sena - Biomedicines, 2024 - mdpi.com
Omentin is an adipokine mainly produced by visceral fat tissue. It has two isoforms, omentin-
1 and omentin-2. Omentin-1 is predominantly secreted by visceral adipose tissue, derived …
1 and omentin-2. Omentin-1 is predominantly secreted by visceral adipose tissue, derived …
Association between omentin-1 and coronary artery disease: Pathogenesis and clinical research
Like other adipokines, omentin-1 is secreted from visceral adipose tissue and plays a vital
role in the development of chronic inflammatory diseases, including cardiovascular events …
role in the development of chronic inflammatory diseases, including cardiovascular events …
Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease
F Biscetti, E Nardella, N Bonadia, F Angelini… - Cardiovascular …, 2019 - Springer
Background Type-2 diabetes mellitus is one of the major risk factors of atherosclerosis,
particularly in peripheral artery disease (PAD). Several studies have documented a …
particularly in peripheral artery disease (PAD). Several studies have documented a …
Evaluation of the association of omentin 1 rs2274907 a> t and rs2274908 g> a gene polymorphisms with coronary artery disease in Indian population: a case control …
Coronary artery disease (CAD) is a major cause of death all over the world. CAD is caused
by atherosclerosis which is induced by the interaction of genetic factors and environmental …
by atherosclerosis which is induced by the interaction of genetic factors and environmental …
Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis
F Genre, J Rueda-Gotor, S Remuzgo-Martínez… - Scientific Reports, 2020 - nature.com
Cardiovascular (CV) disease is the main cause of mortality in axial spondyloarthritis
(axSpA). CV risk is enhanced by dysregulation of adipokines. Low omentin levels were …
(axSpA). CV risk is enhanced by dysregulation of adipokines. Low omentin levels were …
Circulating adiponectin mediates the association between omentin gene polymorphism and cardiometabolic health in Asian Indians
KS Vimaleswaran, D Bodhini, J Jiang, K Ramya… - Plos one, 2021 - journals.plos.org
Background Plasma omentin levels have been shown to be associated with circulating
adiponectin concentrations and cardiometabolic disease-related outcomes. In this study, we …
adiponectin concentrations and cardiometabolic disease-related outcomes. In this study, we …
[PDF][PDF] Role of the rs2274907 allelic variant of the ITLN1 gene in patients with diabetic foot
B Mrozikiewicz-Rakowska, A Sobczyk-Kopcioł… - Pol Arch Intern …, 2017 - ppm.edu.pl
ABSTRACT INTRODUCTION Diabetic foot (DF) is a serious complication of diabetes
mellitus (DM) that occurs due to neuropathy or atherosclerosis of the lower limbs. Omentin …
mellitus (DM) that occurs due to neuropathy or atherosclerosis of the lower limbs. Omentin …
The impact of omentin-1 gene polymorphisms (rs2274907 and rs2274908) on serum lipid concentrations and coronary artery disease in a sample of Iraqi individuals …
Background Coronary artery disease (CAD) is the primary cause of death worldwide. It is
mainly caused by atherosclerosis that initiates from a genetic-environmental interaction …
mainly caused by atherosclerosis that initiates from a genetic-environmental interaction …
Association between intelectin-1 variation and human kidney stone disease in northeastern Thai population
T Pungsrinont, C Nettuwakul, N Sawasdee, N Rungroj… - Urolithiasis, 2021 - Springer
An interplay of multiple genetic and environmental factors implicates an incidence of human
kidney stone disease (KSD). However, the genetic factors associated with KSD are not …
kidney stone disease (KSD). However, the genetic factors associated with KSD are not …
The roles of vaspin, chemerin, and omentin in the determination of metabolic syndrome
Background In general, metabolic syndrome (MetS) is defined as a collection of multiple risk
factors including abdominal obesity, dyslipidaemia, abnormal glycaemia, and elevated …
factors including abdominal obesity, dyslipidaemia, abnormal glycaemia, and elevated …